The response of lung to irradiation is complex, involving killing of lung cells, death of endothelial cells, influx of inflammatory cells and waves of inflammatory cytokines and ROS production. Two major functional outcomes are observed, radiation pneumonitis and radiation fibrosis. Protection against functional and histopathological damage has been demonstrated for a number of different agents when given before irradiation but the extent to which radiation-induced lung damage can be mitigated or treated by agents given only after irradiation is uncertain. The goal of the present proposal is to develop and investigate agents capable of such mitigation and treatment based on the hypothesis that inflammatory cytokines and consequent ROS production play a major role in the development of lung damage. Our previous work in rats has demonstrated that partial volume irradiation of the lower lung can induce damage in the upper (shielded) lung suggesting an inflammatory component to radiation-induced damage. The project has three specific aims.
The first aim i s to extend our preliminary studies with SOD/catalase mimetics to determine their effects when given over different time periods after irradiation. This work will be done in collaboration with the company Eukarion Inc (Core component). The second specific aim is to investigate the mitigating/treatment potential of compounds that can block the induction of the inflammatory response by blocking specific inflammatory signaling pathways. This work will build on our preliminary work demonstrating that Genistein, a protein tyrosine kinase inhibitor, that is a well known dietary supplement and can block the activation of the transcription factor NFkappaB, can mitigate lung damage when given after irradiation.
This aim will determine an optimal treatment protocol for Genistein and will investigate the response of the lung in mice knocked out for specific genes involved in the innate inflammatory response to pinpoint which specific parts of the pathway are important for radiation-induced inflammation in lung. Drugs targeting these specific parts of the pathway will then be tested for their efficacy in mitigating and treating radiation-induced lung injury.
Specific Aim 3 will build on the work undertaken in the previous two aims to study the efficacy of combinations of agents that block ROS and inflammation with the ACE inhibitors and AT blockers being investigated in other projects in this program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI067734-04
Application #
7660461
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
4
Fiscal Year
2008
Total Cost
$372,545
Indirect Cost
Name
Medical College of Wisconsin
Department
Type
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Raber, J; Davis, M J; Pfankuch, T et al. (2017) Mitigating effect of EUK-207 on radiation-induced cognitive impairments. Behav Brain Res 320:457-463
Cohen, Eric P; Fish, Brian L; Moulder, John E (2016) Clinically Relevant Doses of Enalapril Mitigate Multiple Organ Radiation Injury. Radiat Res 185:313-8
Medhora, Meetha; Haworth, Steven; Liu, Yu et al. (2016) Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging. J Nucl Med 57:1296-301
Medda, Rituparna; Lyros, Orestis; Schmidt, Jamie L et al. (2015) Anti inflammatory and anti angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells. Microvasc Res 97:167-80
Medhora, Meetha; Gao, Feng; Glisch, Chad et al. (2015) Whole-thorax irradiation induces hypoxic respiratory failure, pleural effusions and cardiac remodeling. J Radiat Res 56:248-60
Moulder, John E; Cohen, Eric P; Fish, Brian L (2014) Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors. Int J Radiat Biol 90:762-8
Kim, Jae Ho; Jenrow, Kenneth A; Brown, Stephen L (2014) Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J 32:103-15
Medhora, Meetha; Gao, Feng; Wu, Qingping et al. (2014) Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs. Radiat Res 182:545-55
Mahmood, Javed; Jelveh, Salomeh; Zaidi, Asif et al. (2014) Targeting the Renin-angiotensin system combined with an antioxidant is highly effective in mitigating radiation-induced lung damage. Int J Radiat Oncol Biol Phys 89:722-8
Moulder, John E (2014) 2013 Dade W. Moeller lecture: medical countermeasures against radiological terrorism. Health Phys 107:164-71

Showing the most recent 10 out of 75 publications